Novonix Limited

NVX Details
Novonix Limited (ASX: NVX) is a battery materials and technology company that empowers the future for electric vehicles and grid energy storage with operations in the USA and Canada and sales in over 14 countries.

Result Performance – For the first half ended 31 December 2020 – (H1FY21)

Key Data (Source: Company Reports)
Q3FY21 Activity Report
Recent Updates:
As per the release dated 23 June 2021, the company plans for the next phase of development for NOVONIX Anode Materials in Chattanooga, Tennessee. NVX is under contract to purchase agreement and plans to retrofit the former Alstom building.
Key Risks:
The company is exposed to the risks associated with the demand environment. Any slowdown in the demand could hurt the company’s growth as well as expansion plans. Further, the company has signed multiple agreements for R&D and product development, which if goes unfavorable, could impact the company’s plan accordingly.
Outlook:
The company formed a strategic alliance with Harper International to develop specialized furnace technology for battery anode material. Meanwhile, extended growth in R&D services business with tier 1 clients and maintained steady sales in battery testing equipment business. Importantly, announced an update on the planned delivery schedule for the Samsung SDI contract for the NOVONIX Anode Materials synthetic anode material for use in lithium-ion batteries. Further, it is focused on engineering and planning work for 30,000 tpa expansion plant to boost 2025 production targets.
Valuation Methodology: Price/Sales Based Relative Valuation (Illustrative)

Stock Recommendation:
The stock has delivered a one-month return of 16.29%, and 3-months return of 15.28%. The stock is trading above the 52-week high ($4.23) and 52-week low ($0.96) average price. We have applied Price/Sales multiple-based relative valuation (on an illustrative basis) and there are expectations that the stock price might witness a fall of low double-digit (in % terms). We have applied a slight discount to Price/Sales Multiple (NTM) (Peer Average) considering continued losses in the financial performance of the company and longer cash conversion cycle that stood at 237.4 days in H1FY21 vs 140.3 days in H1FY20.
Considering the aforesaid facts, increase in net losses, decent returns, associated risks, and current trading levels, we suggest investors to book profits and wait for a better entry level. Hence, we give a “Sell” recommendation on the stock at the current market price of $2.80 per share, on 14th July 2021 as on 10:08 am (GMT+08:00 Australia Western Time).
Daily Technical Analysis Chart

Source: REFINITIV, Note: Blue color bars reflects daily volumes, Green Color line reflects 21-period SMA, Black Color Line reflects RSI (14-period).
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decisions should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the analysis has been achieved and subject to the factors discussed above alongside support levels provided.
Technical Indicators Defined: -
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine do not hold interests in any of the securities or other financial products covered on the Kalkine website.
Past performance is not a reliable indicator of future performance.